Neostigmine Methyl Sulfate used to treat myasthenia gravis, Ogilvie syndrome, and urinary retention without the presence of a blockage. It is sold under the brand name Prostigmin. Reference standards of Neostigmine Methyl Sulfate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Neostigmine Methyl Sulfate
Catalogue No.:PA 14 69000
CAS :
Molecular Formula : C13H22N2O6S
Molecular Weight : 334.39
3-Hydroxy-N,N,N-trimethylbenzenaminium Methylsulfate
Catalogue No.:PA 14 69010
Molecular Formula : C10H17NO5S
Molecular Weight : 263.31
3-(Dimethylamlno)phenol
Catalogue No.:PA 14 69020
Molecular Formula : C8H11NO
Molecular Weight : 137.18
3-(Dimethylamino)phenyl dimethylcarbamate
Catalogue No.:PA 14 69030
Molecular Formula : C11H16N2O2
Molecular Weight : 208.26
3-Hydroxy-N,N,N-trimethylbenzenaminium Bromide
Catalogue No.:PA 14 0690011
Molecular Formula : C9H14BrNO
Molecular Weight : 232.12
3-Hydroxyphenyltrimethylammonium Iodide
Catalogue No.:PA 14 0690012
Molecular Formula : C9H14INO
Molecular Weight : 279.12
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
